tm logo
AZURITY PHARMACEUTICALS
Live/Registered
REGISTERED

on 24 Nov 2020

Last Applicant/ Owned by

8 CABOT ROAD, SUITE 2000

WOBURN

MA

01801

Serial Number

88452967 filed on 30th May 2019

Registration Number

6206671 registered on 24th Nov 2020

in the Principal Register

Correspondent Address

Douglas R. Wolf

Douglas R. Wolf

600 ATLANTIC AVENUE

BOSTON, MA 02210

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

AZURITY PHARMACEUTICALS

pharmaceutical preparations sold as a kit for use by pharmacists and physicians in creating compounded hormone replacement medicines, topical anti-inflammatory and ultrasound gels, pain and gastrointestinal disorders treatment medicines, and anti-inflammatory, antimicrobial, and antifungal treatment medicines; medicines for the treatment of cardiovascular diseases and disorders, colitis, muscle sp Read More

Classification Information


Class [005]
Pharmaceutical Products


pharmaceutical preparations sold as a kit for use by pharmacists and physicians in creating compounded hormone replacement medicines, topical anti-inflammatory and ultrasound gels, pain and gastrointestinal disorders treatment medicines, and anti-inflammatory, antimicrobial, and antifungal treatment medicines; medicines for the treatment of cardiovascular diseases and disorders, colitis, muscle spasm, infectious diseases, acid-reflux disease, ulcer disease, and urological disorders; antibiotics; pharmaceutical products for the treatment of pain, thyroid disorders, gastrointestinal disorders, gastroesophageal disorders, inflammation, infections, fungal diseases and disorders, cardiovascular diseases and disorders, colitis, muscle spasm, attention deficit hyperactivity disorders, infectious diseases, acid-reflux disease, ulcer disease, and urological disorders having vancomycin, enalapril, lisinopril, and methotrexate as the active pharmaceutical ingredient; antacids; muscle relaxants; hormone replacement medicines; topical anti-inflammatory and ultrasound gels; pharmaceutical preparation for the treatment of pain, thyroid disorders, gastrointestinal disorders, gastroesophageal disorders, inflammation, infections, fungal diseases and disorders, cardiovascular diseases and disorders, colitis, muscle spasm, attention deficit hyperactivity disorders, infectious diseases, acid-reflux disease, ulcer disease, and urological disorders; pharmaceuticals for use in the treatment of cancer and autoimmune diseases and disorders, and for the treatment and prevention of renal, oncological, inflammatory, gastrointestinal, gastroesophageal, and cardio-vascular diseases and disorders


First Use Date in General

31st Aug 2020

First Use Date in Commerce

31st Aug 2020

Mark Details


Serial Number

No 88452967

Mark Type

No Service/Collective Mark

Attorney Docket Number

No C10472003400

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.01.26 -

Spirals, coils and swirls

26.15.13 -

More than one polygon

26.15.21 -

Polygons that are completely or partially shaded

26.15.28 -

Miscellaneous designs with overall polygon shape

Legal History


Show more

Status DateAction Taken
24th Nov 2020REGISTERED-PRINCIPAL REGISTER
22nd Oct 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
21st Oct 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
21st Oct 2020STATEMENT OF USE PROCESSING COMPLETE
20th Oct 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
06th Oct 2020USE AMENDMENT FILED
06th Oct 2020TEAS STATEMENT OF USE RECEIVED
29th Apr 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
28th Apr 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03rd Mar 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED